Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Gynecology

Treatment Options for Adenomyosis

At a Glance

The best treatment for adenomyosis depends on your specific symptoms and future pregnancy goals. Options range from hormonal therapies like Dienogest and Mirena for symptom management, to non-invasive HIFU procedures, conservative surgery, or a hysterectomy as a permanent cure.

Choosing a treatment for adenomyosis is a deeply personal process. Because this condition is driven by your hormones and affects the very structure of your uterus, the “right” choice depends entirely on your specific symptoms and whether you hope to become pregnant in the future [1][2].

Medical Management: Silencing the Cycle

The first line of defense is often hormonal therapy, designed to stop the “vicious cycle” of estrogen and inflammation that fuels the disease [3].

  • Dienogest (DNG): This is a specialized progestin pill often used specifically for adenomyosis and endometriosis. Research suggests it may be more effective than other options for reducing pelvic pain and severe cramping [4][5]. It can also help prevent the uterus from growing larger [6]. Note that while highly effective, it may be prescribed “off-label” for adenomyosis depending on your country (such as in the US, where it is primarily FDA-approved for endometriosis).
  • LNG-IUS (Mirena): This hormonal IUD is highly effective at reducing heavy menstrual bleeding [7]. However, because adenomyosis can enlarge the uterus, there is a higher risk that the body might accidentally expel the device [8]. Some doctors use a specialized suture technique to keep it in place [9].
  • GnRH Agonists: These medications temporarily put the body into a “pseudo-menopause” state, shrinking the lesions and providing significant relief [10][11]. While effective, these drugs can cause severe menopausal side effects (like hot flashes, mood changes, and bone density loss). To manage this, doctors often prescribe “add-back” hormone therapy to protect your bone health and maintain your quality of life.

Non-Invasive Options: HIFU

High-Intensity Focused Ultrasound (HIFU) is a modern, non-surgical alternative for those who wish to avoid incisions. It works by focusing ultrasound waves into a single “hot spot” inside the uterine wall, destroying the diseased tissue while leaving the surrounding healthy muscle intact [12][13].

  • HIFU is often combined with hormonal treatments to maximize success, especially in diffuse adenomyosis [14].
  • Keep in mind that while HIFU is promising, it may not be widely available at all clinics, and insurance coverage can vary. It is a “uterine-sparing” option, meaning it allows you to keep your uterus and potentially pursue pregnancy later, though more research is needed on long-term fertility outcomes [15][16].

Conservative Surgery: Adenomyomectomy

While a myomectomy for fibroids is usually straightforward, an adenomyomectomy is technically much harder. This is because adenomyosis doesn’t have a clear boundary; the diseased tissue is “woven” into the healthy muscle [17][2].

  • The goal is to remove as much diseased tissue as possible while rebuilding the uterine wall [18].
  • Risks and Recurrence: There is a significant risk of the disease returning, especially if the lesions are on the back (posterior) wall of the uterus [19].
  • Pregnancy Concerns: Because of the weakened uterine wall, if you become pregnant after this surgery, you will almost universally require a scheduled Cesarean section (C-section) prior to labor to prevent uterine rupture [20].

Definitive Treatment: Hysterectomy

A hysterectomy (removal of the uterus) remains the only permanent cure for adenomyosis [21]. For patients who have completed their families and are suffering from life-altering pain and bleeding, this can offer a definitive resolution and a high satisfaction rate [22]. However, it is important to remember that a hysterectomy is a choice, not a requirement. It should be considered only when you feel ready and other options have been fully discussed [1].

A Decision-Making Roadmap

If your goal is… Consider starting with…
Immediate Pregnancy GnRH agonists to “quiet” the disease before IVF or conception [23].
Future Pregnancy Dienogest, LNG-IUS, or HIFU to manage symptoms while preserving the uterus [24][15].
Symptom Relief (No Pregnancy) LNG-IUS, Uterine Artery Embolization (UAE), or Hysterectomy [25][21].

Return to Home Page

Common questions in this guide

Does a hysterectomy cure adenomyosis?
Yes, a hysterectomy is currently the only permanent cure for adenomyosis. It is generally considered a definitive option for patients who have completed their families and suffer from severe pain or bleeding that has not responded to other treatments.
What is the best medication for adenomyosis pain?
Hormonal therapies are typically the first line of defense. Dienogest, a specialized progestin pill, is frequently used because it is highly effective at reducing the severe pelvic pain and cramping associated with the condition.
Can I get pregnant after an adenomyosis surgery?
Pregnancy is possible after uterus-sparing treatments like HIFU or conservative surgery. However, if you undergo an adenomyomectomy, you will almost universally require a scheduled C-section for future deliveries to prevent uterine rupture during labor.
What is HIFU for adenomyosis?
High-Intensity Focused Ultrasound (HIFU) is a non-surgical procedure that uses focused sound waves to target and destroy diseased tissue in the uterine wall. It is an option for women who want to treat their symptoms while preserving their uterus.
Why do doctors prescribe GnRH agonists for adenomyosis?
These medications put the body into a temporary, menopause-like state to shrink adenomyosis lesions and reduce inflammation. Because they can cause menopausal side effects and bone density loss, doctors often prescribe them alongside add-back hormone therapy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms and imaging, would you recommend dienogest or the LNG-IUS as a first-line treatment?
  2. 2.If we proceed with a GnRH agonist, what specific 'add-back' therapy will you prescribe to protect my bone density and manage menopausal symptoms?
  3. 3.Am I a candidate for HIFU, and is it effective for the specific subtype (focal or diffuse) that I have?
  4. 4.If we consider an adenomyomectomy, how do you distinguish between the diseased tissue and healthy muscle during the procedure?
  5. 5.What are the specific risks to a future pregnancy if I undergo a conservative surgery or HIFU?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    The etiology differs regards to the locations of the lesion: a clinical experience of 1350 patients with adenomyosis confirmed by postoperative pathology.

    Li W, Hang Y, Xu Y, et al.

    BMC women's health 2025; (25(1)):268 doi:10.1186/s12905-025-03759-3.

    PMID: 40448071
  2. 2

    Adenomyosis-A Call for Awareness, Early Detection, and Effective Treatment Strategies: A Narrative Review.

    Kolovos G, Dedes I, Imboden S, Mueller M

    Healthcare (Basel, Switzerland) 2024; (12(16)) doi:10.3390/healthcare12161641.

    PMID: 39201199
  3. 3

    The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies.

    Li F, Wang HJ, Zhang Y, et al.

    Seminars in immunopathology 2026; (48(1)).

    PMID: 42258013
  4. 4

    Comparison of the effectiveness of levonorgestrel intrauterine system and dienogest in the management of adenomyosis: A systematic review and meta-analysis.

    Akhigbe RE, Afolabi OA, Adegbola CA, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2024; (300()):230-239 doi:10.1016/j.ejogrb.2024.07.038.

    PMID: 39032312
  5. 5

    Long-term dienogest administration in patients with symptomatic adenomyosis.

    Neriishi K, Hirata T, Fukuda S, et al.

    The journal of obstetrics and gynaecology research 2018; (44(8)):1439-1444 doi:10.1111/jog.13674.

    PMID: 29845696
  6. 6

    Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.

    Guo W, Lin Y, Hu S, Shen Y

    Clinical therapeutics 2023; (45(10)):973-976 doi:10.1016/j.clinthera.2023.07.019.

    PMID: 37599165
  7. 7

    Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding.

    Yang H, Wang S, Fu X, et al.

    The journal of obstetrics and gynaecology research 2022; (48(1)):161-168 doi:10.1111/jog.15031.

    PMID: 34672405
  8. 8

    An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.

    Zhang H, Cao B, Tong J, et al.

    BMC women's health 2022; (22(1)):451 doi:10.1186/s12905-022-01932-6.

    PMID: 36384588
  9. 9

    Clinical value of hysteroscopic levonorgestrel intrauterine system suture fixation in treating adenomyosis.

    Wang J, Gong L, Xin Y, et al.

    BMC women's health 2025; (25(1)):482 doi:10.1186/s12905-025-04040-3.

    PMID: 41068725
  10. 10

    Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis.

    Liang Z, Yin M, Ma M, et al.

    Reproductive biomedicine online 2019; (39(1)):111-118 doi:10.1016/j.rbmo.2019.03.101.

    PMID: 31109894
  11. 11

    Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study.

    Xiao-Ying Z, Ying-Shu G, Jiu-Mei C, et al.

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2018; (34(8)):1289-1297 doi:10.1080/02656736.2018.1440014.

    PMID: 29447020
  12. 12

    Progress in High Intensity Focused Ultrasound Ablation for Fertility Preservation Therapy of Uterine Fibroids and Adenomyosis.

    Zhang G, Li L, Sun M, Yu X

    Reproductive sciences (Thousand Oaks, Calif.) 2025; (32(1)):15-25 doi:10.1007/s43032-024-01745-y.

    PMID: 39532767
  13. 13

    High-Intensity Focused Ultrasound (HIFU) in Pancreatic Cancer-Related Pain: Current Evidence and Future Directions.

    Liu Y, Chen M, Liu L, et al.

    Ultrasound in medicine & biology 2025; (51(10)):1639-1645 doi:10.1016/j.ultrasmedbio.2025.05.032.

    PMID: 40670261
  14. 14

    High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects.

    Bahutair SN, Alhubaishi LY

    Women's health (London, England) 2024; (20()):17455057241295593 doi:10.1177/17455057241295593.

    PMID: 39494764
  15. 15

    Pregnancy outcomes of adenomyotic patients with primary infertility after high-intensity focused ultrasound treatment.

    Xiong L, Cheng W, Wang Z, Shi Q

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2023; (40(1)):2264547 doi:10.1080/02656736.2023.2264547.

    PMID: 37903541
  16. 16

    Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment.

    Hai N, Hou Q, Guo R

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2021; (38(1)):65-69 doi:10.1080/02656736.2021.1874063.

    PMID: 33472465
  17. 17

    The Pumpkin method - An innovative uterus-preserving surgery for large complex adenomyosis: A preliminary experience.

    Kung CH, Leung-Chit Tsang L, Chen WH, et al.

    Taiwanese journal of obstetrics & gynecology 2025; (64(6)):1009-1016 doi:10.1016/j.tjog.2025.07.024.

    PMID: 41213746
  18. 18

    Uterus-preserving surgery for diffuse adenomyosis via transumbilical single-port laparoscopy: combining dual-flap reconstruction and temporary uterine artery occlusion.

    Cao Y, Tian J, Liu X, Nie J

    Fertility and sterility 2026; (125(3)):536-539 doi:10.1016/j.fertnstert.2025.12.014.

    PMID: 41443365
  19. 19

    Recurrence rates and associated risk factors after conservative surgery for adenomyosis: a retrospective study.

    Lu K, Zhong G, Lian B, et al.

    BMC women's health 2024; (24(1)):619 doi:10.1186/s12905-024-03457-6.

    PMID: 39578802
  20. 20

    Uterine adenomyosis and adenomyoma: the surgical approach.

    Osada H

    Fertility and sterility 2018; (109(3)):406-417 doi:10.1016/j.fertnstert.2018.01.032.

    PMID: 29566853
  21. 21

    The Value of Adenomyosis Type in Clinical Assessment: A Single-center Experience of 755 Nodular and Diffuse Adenomyosis Cases.

    Selvi Demirtas G, Uyar I

    Archives of Iranian medicine 2021; (24(5)):374-382 doi:10.34172/aim.2021.54.

    PMID: 34196202
  22. 22

    Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.

    Bianchi P, Guo SW, Habiba M, Benagiano G

    Journal of clinical medicine 2022; (11(19)) doi:10.3390/jcm11195836.

    PMID: 36233703
  23. 23

    Effects of pretreatment strategies on fertility outcomes in patients with adenomyosis.

    Moawad G, Youssef Y, Fruscalzo A, et al.

    Frontiers in reproductive health 2024; (6()):1484202 doi:10.3389/frph.2024.1484202.

    PMID: 39717429
  24. 24

    Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.

    Choudhury S, Jena SK, Mitra S, et al.

    Therapeutic advances in reproductive health 2024; (18()):26334941241227401 doi:10.1177/26334941241227401.

    PMID: 38283750
  25. 25

    Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy.

    Dessouky R, Gamil SA, Nada MG, et al.

    Insights into imaging 2019; (10(1)):48 doi:10.1186/s13244-019-0732-8.

    PMID: 31030317

This page provides educational information on adenomyosis treatments and fertility considerations. Always consult your gynecologist or reproductive specialist to determine the safest treatment plan for your specific symptoms and family planning goals.

Get notified when new evidence is published on adenomyosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.